Abstract
In this chapter, after the presentation of the expression of Chromogranin A and its antimicrobial derived peptides in circulation, we report a clinical analysis for Vasostatin-I (VS-I) and the preparation of antimicrobial coating with Cateslytin (CTL). In a clinical multicenter analysis of VS-I in the plasma of critically ill patients (481 patients and 13 healthy staff), we have shown for the first time, that an increase in the VS-I concentration was present on admission in non-selected critically ill patients and that it was associated with poor outcome at day 28 after admission. By using a combination of VS-I, lactate and age values, our assessment of prognosis was better than taking the parameters alone. Concerning the preparation of antimicrobial biomaterial we decided to use polysaccharide multilayer film based on CTL functionalized hyaluronic acid as polyanion and chitosan as polycation, (HA-CTL-C/CHI), with the aim of designing a self-defensive coating against both bacteria (Staphylococcus aureus) and yeast (Candida albicans). The ability of S. aureus and Candida species to degrade HA, by producing hyaluronidase, allows the active peptide to be released from film only in the presence of the pathogens. We have demonstrated the antimicrobial activities of HA-CTL in solution and HA-CTL-C/CHI films against S. aureus and C. albicans. We have shown the penetration of the fluorescently labeled HA FITC -CTL-C into the cell membrane of C. albicans and the cytotoxicity of HA-CTL-C/CHI films was tested through human gingival fibroblasts (HGFs) viability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aardal S, Helle KB (1992) The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept 41(1):9–18
Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G (1993) Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5(4):405–412
Aerts AM, François IE, Cammue BP, Thevissen K (2008) The mode of antifungal action of plant, insect and human defensins. Cell Mol Life Sci 65(13):2069–2079
Arnold R, Wilke A, Rinke A, Mayer C, Kann PH, Klose KJ et al (2008) Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol 6(7):820–827
Aslam R, Laventie BJ, Marban C, Prévost G, Keller D, Strub JM et al (2013a) Activation of neutrophils by the two-component leukotoxin LukE/D from Staphylococcus aureus: proteomic analysis of the secretions. J Proteome Res 12(8):3667–3678
Aslam R, Marban C, Corazzol C, Jehl F, Delalande F, Van Dorsselaer A et al (2013b) Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases. PLoS One 8(7):e68993
Biswas N, Rodriguez-Flores JL, Courel M, Gayen JR, Vaingankar SM, Mahata M et al (2009) Cathepsin L colocalizes with chromogranin A in chromaffin vesicles to generate active peptides. Endocrinology 150(8):3547–3557
Blois A, Holmsen H, Martino G, Corti A, Metz-Boutigue MH, Helle KB (2006) Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine. Regul Pept 134(1):30–37
Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S et al (2005) New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci 62(3):377–385
Brosig B, Langosch D (1998) The dimerization motif of the glycophorin A transmembrane segment in membranes: importance of glycine residues. Protein Sci 7(4):1052–1056
Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26(Suppl 1):S64–S74
Bulet P, Stöcklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198(1):169–184
Cado G, Aslam R, Séon L, Garnier T, Fabre R, Parat A, Chassepot A, Voegel JC, Senger V, Schneider F, Frère Y, Jierry L, Schaaf P, Kerdjoudj H, Metz-Boutigue MH, Boulmedais F (2013) Self-defensive biomaterial coating against bacteria and yeasts: polysaccharide multilayer film with embedded antimicrobial peptide. Adv Funct Mater 23:4801–4809
Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B et al (2002) Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 23(12):967–974
Corti A, Ferrari R, Ceconi C (2000) Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure. Adv Exp Med Biol 482:351–359
Cryer PE, Wortsman J, Shah SD, Nowak RM, Deftos LJ (1991) Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Phys 260(2 Pt 1):E243–E246
Decher G (1997) Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 277(5330):1232–1237
Di Comite G, Marinosci A, Di Matteo P, Manfredi A, Rovere-Querini P, Baldissera E et al (2006) Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann N Y Acad Sci 1069:428–437
Di Comite G, Rossi CM, Marinosci A, Lolmede K, Baldissera E, Aiello P et al (2009) Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. J Leukoc Biol 85(1):81–87
Eiden LE (1987) Is chromogranin a prohormone? Nature 325(6102):301
Evangelista R, Ray P, Lewis RV (1982) A “trypsin-like” enzyme in adrenal chromaffin granules: a proenkephalin processing enzyme. Biochem Biophys Res Commun 106(3):895–902
Fournier I, Gaucher D, Chich JF, Bach C, Shooshtarizadeh P, Picaud S et al (2011 Feb) Processing of chromogranins/secretogranins in patients with diabetic retinopathy. Regul Pept 167(1):118–124
Gao BB, Chen X, Timothy N, Aiello LP, Feener EP (2008) Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 7(6):2516–2525
Glattard E, Angelone T, Strub JM, Corti A, Aunis D, Tota B et al (2006) Characterization of natural vasostatin-containing peptides in rat heart. FEBS J 273(14):3311–3321
Glinel K, Thebault P, Humblot V, Pradier CM, Jouenne T (2012) Antibacterial surfaces developed from bio-inspired approaches. Acta Biomater 8(5):1670–1684
Gribova V, Auzely-Velty R, Picart C (2012) Polyelectrolyte multilayer assemblies on materials surfaces: from cell adhesion to tissue engineering. Chem Mater 24(5):854–869
Guérin M, Guillemot J, Thouënnon E, Pierre A, El-Yamani FZ, Montero-Hadjadje M, Dubessy C, Magoul R, Lihrmann I, Anouar Y, Yon L (2010) Granins and their derived peptides in normal and tumoral chromaffin tissue: implications for the diagnosis and prognosis of pheochromocytoma. Regul Pept 165(1):21–29
Guggenbichler JP, Assadian O, Boeswald M, Kramer A (2011) Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip 6(1):Doc18
Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al (2001) Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396–402
Harriott MM, Noverr MC (2009) Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 53(9):3914–3922
Helle KB (2010) Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system. Results Probl Cell Differ 50:21–44
Helle KB, Serck-Hanssen G (1975) The adrenal medulla: a model for studies of hormonal and neuronal storage and release mechanisms. Mol Cell Biochem 6(2):127–146
Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64(22):2863–2886
Hilchie AL, Wuerth K, Hancock RE (2013) Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 9(2):761–768
Hook VY, Metz-Boutigue MH (2002) Protein trafficking to chromaffin granules and proteolytic processing within regulated secretory vesicles of neuroendocrine chromaffin cells. Ann N Y Acad Sci 971:397–405
Hook VY, Eiden LE, Brownstein MJ (1982) A carboxypeptidase processing enzyme for enkephalin precursors. Nature 295(5847):341–342
Jansson AM, Røsjø H, Omland T, Karlsson T, Hartford M, Flyvbjerg A et al (2009) Prognostic value of circulating chromogranin A levels in acute coronary syndromes. Eur Heart J 30(1):25–32
Larkin EA, Carman RJ, Krakauer T, Stiles BG (2009) Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr Med Chem 16(30):4003–4019
Lauhio A, Hastbacka J, Pettila V, Tervahartiala T, Karlsson S, Varpula T et al (2011) Serum MMP-8, −9 and TIMP- 1 in sepsis: high serum levels of MMP- 8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 64(6):590–594
Lee WL, Downey GP (2000) Coagulation inhibitors in sepsis and disseminated intravascular coagulation. Intensive Care Med 26(11):1701–1706
Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P et al (2000) Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin a. J Biol Chem 275(15):10745–10753
Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B et al (2001) Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J Biol Chem 276(38):35875–35882
Maget-Dana R, Metz-Boutigue MH, Helle KB (2002) The N-terminal domain of chromogranin A (CgA1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions. Ann N Y Acad Sci 971:352–354
Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H et al (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100(6):1623–1633
Manners JM (2007) Hidden weapons of microbial destruction in plant genomes. Genome Biol 8(9):225
Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D (1993) Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217(1):247–257
Metz-Boutigue MH, Goumon Y, Lugardon K, Strub JM, Aunis D (1998) Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol 18(2):249–266
Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y (2008) Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192(2):309–324
Nakano I, Funakoshi A, Miyasaka K, Ishida K, Makk G, Angwin P et al (1989) Isolation and characterization of bovine pancreastatin. Regul Pept 25(2):207–213
Nikou GC, Marinou K, Thomakos P, Papageorgiou D, Sanzanidis V, Nikolaou P et al (2008) Chromogranin A levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours. Pancreatology 8(4–5):510–519
O’Connor DT, Bernstein KN (1984) Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311(12):764–770
O’Connor DT, Cervenka JH, Stone RA, Parmer RJ, Franco-Bourland RE, Madrazo I et al (1993) Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity and variation in neurological disease. Neuroscience 56(4):999–1007
Paniagua-Contreras G, Sáinz-Espuñes T, Monroy-Pérez E, Rodríguez-Moctezuma JR, Arenas-Aranda D, Negrete-Abascal E et al (2012) Virulence markers in Staphylococcus aureus strains isolated from hemodialysis catheters of Mexican patients. Adv Microbiol 2(4):476–487
Parmer RJ, Mahata SK, Jiang O, Taupenot L, Gong Y, Mahata M et al (2000) Tissue plasminogen activator and chromaffin cell function. Adv Exp Med Biol 482:179–192
Ramage G, Martínez JP, López-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6(7):979–986
Riva R, Ragelle H, des Rieux A, Duhem N, Jerome C, Preat V (2011) Chitosan and chitosan derivatives in drug delivery and tissue engineering. Chitosan for biomaterials II. Springer, Berlin, Heidelberg, pp 19–44
Roatta S, Passatore M, Novello M, Colombo B, Dondossola E, Mohammed M et al (2011) The chromogranin A-derived N-terminal peptide vasostatin-I: in vivo effects on cardiovascular variables in the rabbit. Regul Pept 168(1–3):10–20
Schneider F, Bach C, Chung H, Crippa L, Lavaux T, Bollaert PE et al (2012) Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance. Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance. Intensive Care Med 38(9):1514–1522
Seidah NG, Chrétien M (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848(1–2):45–62
Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G (1977) Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Arch Intern Med 137(11):1562–1567
Shimizu MT, Almeida NQ, Fantinato V, Unterkircher CS (1996) Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses 39(5–6):161–167
Shooshtarizadeh P, Zhang D, Chich JF, Gasnier C, Schneider F, Haïkel Y et al (2010) The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept 165(1):102–110
Sternberg EM (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6(4):318–328
Stridsberg M, Eriksson B, Oberg K, Janson ET (2004) A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. Regul Pept 117(3):219–227
Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M et al (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271(45):28533–28540
Taupenot L, Harper KL, O'Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348(12):1134–1149
Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S et al (2000) Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem 275(30):22905–22915
Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD et al (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278(4):2731–2739
Tota B, Quintieri AM, Di Felice V, Cerra MC (2007) New biological aspects of chromogranin A-derived peptides: focus on vasostatins. Comp Biochem Physiol A Mol Integr Physiol 147(1):11–18
Tota B, Cerra MC, Gattuso A (2010) Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a ‘whip-brake’ system of the endocrine heart. J Exp Biol 213(Pt 18):3081–3103
Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B et al (2007) Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 33(6):970–977
Turquier V, Vaudry H, Jégou S, Anouar Y (1999) Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A gene expression in the pars intermedia of the pituitary during background color adaptation. Endocrinology 140(9):4104–4112
Volpi N, Schiller J, Stern R, Soltés L (2009) Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem 16(14):1718–1745
Von Eiff C, Jansen B, Kohnen W, Becker K (2005) Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65(2):179–214
Wang G, Li X, Wang Z (2016) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44(D1):D1087–D1093
Wortsman J, Frank S, Cryer PE (1984) Adrenomedullary response to maximal stress in humans. Am J Med 77(5):779–784
Yazdan-Ashoori P, Liaw P, Toltl L, Webb B, Kilmer G, Carter DE et al (2011) Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis. J Crit Care 26(6):556–565
Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27–55
Yoo SH (1992) Identification of the Ca(2+)-dependent calmodulin-binding region of chromogranin A. Biochemistry 31(26):6134–6140
Yoshida C, Ishikawa T, Michiue T, Zhao D, Komatsu A, Quan L et al (2009) Immunohistochemical distribution of chromogranin A in medicolegal autopsy materials. Leg Med (Tokyo) 11(Suppl 1):S231–S233
Zhang D, Lavaux T, Voegeli AC, Lavigne T, Castelain V, Meyer N et al (2008) Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit. Clin Chem 54(9):1497–1503
Zhang D, Lavaux T, Sapin R, Lavigne T, Castelain V, Aunis D et al (2009a) Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients. Ann Med 41(1):38–44
Zhang D, Shooshtarizadeh P, Laventie BJ, Colin DA, Chich JF, Vidic J et al (2009b) Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS One 4(2):e4501
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Metz-Boutigue, MH., Schneider, F. (2017). Involvement of Chromogranin A and Its Derived Peptides to Fight Infections. In: Angelone, T., Cerra, M., Tota, B. (eds) Chromogranins: from Cell Biology to Physiology and Biomedicine. UNIPA Springer Series. Springer, Cham. https://doi.org/10.1007/978-3-319-58338-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-58338-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58337-2
Online ISBN: 978-3-319-58338-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)